Navigation Links
ImpactRx Releases 2010 Oncology Promotion Report

MOUNT LAUREL, N.J., Jan. 31, 2011 /PRNewswire/ -- ImpactRx, a pioneer in tracking and evaluating pharmaceutical promotion on the prescribing behavior of physicians, completed its annual review of the detailing efforts of pharmaceutical/biotech sales representatives in oncology offices.  The results have just been published in the January 2011 edition of Oncology Business Review.

ImpactRx's mobile pharmaceutical market research system offers a longitudinal network of 475 oncologists who use iPhone technology and proprietary software to provide real-time data about sales representative promotion, meeting and event participation and patient treatment options.  This year the data was supplemented with research into physicians' online behavior provided through a joint offering ImpactRx has with comScore, a global leader in measuring digital traffic and readership.  The result is a unique view of the promotional landscape in the fast-paced and ever-changing oncology market, helping pharmaceutical companies make the most of every minute with key physicians.

According to Richard Altus, President and CEO of ImpactRx, "Given the recent changes in the pharmaceutical and biotech industries, face time with oncologists is more valuable than ever.  This data helps refine brand and targeting strategies to ensure that the right message gets to the right physicians, providing an optimized and powerful marketing strategy."

Click here  to download "The 3rd Annual Outlook on the Pharmaceutical Promotional Landscape within Oncology".

Key data highlighted in the article includes:

  • Share of Attention – Sales Representative Oncology Product Details 2006-2010
  • Top 25 Products Detailed by Sales Representatives 2009/2010
  • Oncology Sales Force Top Tier Rating 2010
  • Reach of Healthcare Websites  (Jan – Sept 2010)
  • Average Number of Visits per Month (Jan – Sept 2010)

  • About ImpactRx

    Founded in 2000 and headquartered in Mount Laurel, NJ, ImpactRx's longitudinal panel of high prescribing, smart phone-connected physicians is the exclusive source of continuously captured promotion and treatment data.  Through its proprietary methodology, the Company captures annually one million details and three million treatment decisions, fueling its unique industry database.  ImpactRx leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers.  Visit ImpactRx at AguilarSagefrog Marketing Group,

    SOURCE ImpactRx
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. ImpactRx Tracks Decline in Zetia and Vytorin Prescribing
    2. Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions
    3. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
    4. CEL-SCI Corporation Releases Letter to Shareholders
    5. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
    6. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
    7. Immunosyn Corporation Releases SF-1019 Study Results
    8. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
    9. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
    10. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
    11. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
    Post Your Comments:
    (Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
    (Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
    (Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
    Breaking Medicine Technology:
    (Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
    (Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
    (Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
    (Date:6/24/2016)... New York, NY (PRWEB) , ... June 24, ... ... lifestyle publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as ... believes that “the most beautiful women in the world, and the most handsome ...
    (Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
    Breaking Medicine News(10 mins):